Humoral immune response to HSV‐1 and HSV‐2 viral proteins in patients with primary genital herpes
Authors:
- 1 October 1985
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 17 (2) , 153-166
Abstract
The humoral immune response to HSV‐1 and HSV‐2 proteins was examined in patients with primary first‐episode genital herpes. Ten patients had culture‐proven HSV‐1 infections, 37 had HSV‐2 infections, and all were seronegative to HSV proteins before developing their infections. Development of serum antibodies to individual HSV proteins and glycoproteins was determined by immunoprecipitation of radiolabeled HSV‐1‐ and HSV‐2‐ infected cell proteins and subsequent gel electrophoresis. In HSV‐1 patients, a sequential development of antibodies to HSV‐1 proteins was observed with early appearance of antibodies to the nucleocapsid protein p148 and to glycoproteins gB and gC. Seroconversion to gD and to a polypeptide of 88,000 molecular weight (p88) occurred next, and, finally, seroconversion to gE and to a nonglycosylated 66,000 dalton protein p66. In HSV‐2 patients, antibodies to HSV‐2 proteins p148, gB, and p88 appeared within 1 week of onset of symptoms. Seroconversion to p66, gD, and to a complex of glycoproteins gC and gE (g80) occurred later, at a mean time of approximately 3 weeks. Seroconversion to HSV‐1 gB, p88, and p66 occurred significantly later than seroconversion to the homologous counterparts. Seroconversion within 21 days of onset to HSV‐2 gD, g80, and p66 was associated with a longer time to the first recurrence in HSV‐2 patients, suggesting a possible role of these antibodies, alone or in combination, in the maintenance of HSV‐2 latency in humans.Keywords
This publication has 32 references indexed in Scilit:
- Relative Titers of Antibodies to Individual Polypeptide Antigens of Herpes Simplex Virus Type 1 in Human SeraThe Journal of Infectious Diseases, 1983
- Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and ComplicationsAnnals of Internal Medicine, 1983
- Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infectionsThe American Journal of Medicine, 1982
- A Trial of Topical Acyclovir in Genital Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1982
- Antibody Response to Herpes Simplex Virus Type 1 Polypeptides and Glycoproteins in Primary and Recurrent InfectionPediatric Research, 1982
- Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.Proceedings of the National Academy of Sciences, 1981
- Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow TransplantThe Journal of Infectious Diseases, 1980
- Fluorographic detection of radioactivity in polyacrylamide gols with the water-soluble fluor, sodium salicylateAnalytical Biochemistry, 1979
- Cellular Immune Response in Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1978
- ANTIBODIES TO HERPESVIRUS HOMINIS TYPES 1 AND 2 IN HUMANS1American Journal of Epidemiology, 1970